EE+ POEM Archive
Continuing warfarin for 18 months after unprovoked PE reduces risk of recurrent VTE
There's more to see -- the rest of this topic is available only to subscribers.
Citation
Barry, Henry, et al., editors. "Continuing Warfarin for 18 Months After Unprovoked PE Reduces Risk of Recurrent VTE." EE+ POEM Archive, John Wiley & Sons, 2025. Evidence Central, evidence.unboundmedicine.com/evidence/view/infoPOEMs/428409/all/Continuing warfarin for 18 months after unprovoked PE reduces risk of recurrent VTE.
Continuing warfarin for 18 months after unprovoked PE reduces risk of recurrent VTE. In: Barry HH, Ebell MHM, Shaughnessy AFA, et al, eds. EE+ POEM Archive. John Wiley & Sons; 2025. https://evidence.unboundmedicine.com/evidence/view/infoPOEMs/428409/all/Continuing warfarin for 18 months after unprovoked PE reduces risk of recurrent VTE. Accessed May 12, 2025.
Continuing warfarin for 18 months after unprovoked PE reduces risk of recurrent VTE. (2025). In Barry, H., Ebell, M. H., Shaughnessy, A. F., & Slawson, D. C. (Eds.), EE+ POEM Archive. John Wiley & Sons. https://evidence.unboundmedicine.com/evidence/view/infoPOEMs/428409/all/Continuing warfarin for 18 months after unprovoked PE reduces risk of recurrent VTE
Continuing Warfarin for 18 Months After Unprovoked PE Reduces Risk of Recurrent VTE [Internet]. In: Barry HH, Ebell MHM, Shaughnessy AFA, Slawson DCD, editors. EE+ POEM Archive. John Wiley & Sons; 2025. [cited 2025 May 12]. Available from: https://evidence.unboundmedicine.com/evidence/view/infoPOEMs/428409/all/Continuing warfarin for 18 months after unprovoked PE reduces risk of recurrent VTE.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Continuing warfarin for 18 months after unprovoked PE reduces risk of recurrent VTE
ID - 428409
ED - Barry,Henry,
ED - Ebell,Mark H,
ED - Shaughnessy,Allen F,
ED - Slawson,David C,
BT - EE+ POEM Archive
UR - https://evidence.unboundmedicine.com/evidence/view/infoPOEMs/428409/all/Continuing warfarin for 18 months after unprovoked PE reduces risk of recurrent VTE
PB - John Wiley & Sons
DB - Evidence Central
DP - Unbound Medicine
ER -
